Microba Life Sciences Limited (MAP) is a Company that is engaged in microbiome testing, supplements and analysis services as well as developing new pathology services, therapeutics and diagnostics based on the human gut microbiome.
Find out what a historical investment in Microba Life Sciences would be worth today using our MAP stock calculator.
Buying MAP shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Microba Life Sciences in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in MAP
What is the ticker symbol of Microba Life Sciences?
The ticker symbol for Microba Life Sciences is MAP.
How much is one share of MAP?
One share of MAP is valued at $0.04 as of 22 November 2026.
What is the market capitalisation of Microba Life Sciences MAP?
As of 22 November 2026 Microba Life Sciences has a market cap of $26.74M.
What is the P/E ratio of MAP?
The Price to Earnings ratio of MAP is -1.04.
What is the Earnings Per Share of MAP?
The Earnings Per Share of MAP is -$0.03.
What is the 52-week high for Microba Life Sciences stock?
The Microba Life Sciences 52-week high stock price is $0.11.
What is the 52-week low for Microba Life Sciences stock?
The Microba Life Sciences 52-week low stock price is $0.03.
Can I buy MAP shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy MAP shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.